CCM
NPSP

Consonance Capital Management’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Consonance Capital Management’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,355,152
Closed -$43.1M – 31
2013
Q3 		$43.1M Sell
1,355,152
-484,111
-26% -$11.1M 10.78% 1
2013
Q2 		$27.8M Buy
+1,839,263
New +$25.5M 9.88% 2

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Consonance Capital Management's NPSP Position: Q4 2013 in Review

Consonance Capital Management sold out of NPS PHARMACEUTICALS INC (NPSP) in Q4 2013, closing a stake of 1,355,152 shares — an estimated $43.1M sold.

Consonance Capital Management first reported a position in NPSP in Q2 2013 and held it in 2 quarters. The position peaked at $43.1M in Q3 2013. 191 funds tracked by Wall St. Rank hold NPSP as of Q4 2013.

  • Consonance Capital Management reported no remaining NPS PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Consonance Capital Management sold 1,355,152 NPS PHARMACEUTICALS INC shares in Q4 2013, an estimated $43.1M.
  • Consonance Capital Management first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Consonance Capital Management's NPS PHARMACEUTICALS INC position peaked at $43.1M in Q3 2013.
  • 191 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q4 2013.

Based on Consonance Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.